Phase II Trial of Primary Radiotherapy With Androgen Ablation With or Without Adjuvant Niraparib for Selected High-Risk Locoregional Prostate Cancer
Latest Information Update: 30 May 2024
At a glance
- Drugs Abiraterone acetate (Primary) ; Niraparib (Primary) ; Prednisone (Primary) ; Antiandrogens; Apalutamide
- Indications Prostate cancer
- Focus Therapeutic Use
- 05 Aug 2021 Status changed from not yet recruiting to recruiting.
- 09 Jul 2021 New trial record